{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:27:44Z","timestamp":1787020064790,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["821707171"],"award-info":[{"award-number":["821707171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["821707171"],"award-info":[{"award-number":["821707171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenic multisystem disease caused primarily by mutations in the\n                      <jats:italic>PKD1<\/jats:italic>\n                      gene or\n                      <jats:italic>PKD2<\/jats:italic>\n                      gene. There is increasing evidence that some of these variants, which are described as missense, synonymous or nonsense mutations in the literature or databases, may be deleterious by affecting the pre-mRNA splicing process.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study aimed to determine the effect of these\n                      <jats:italic>PKD1<\/jats:italic>\n                      and\n                      <jats:italic>PKD2<\/jats:italic>\n                      variants on exon splicing combined with predictive bioinformatics tools and minigene assay. As a result, among the 19 candidate single nucleotide alterations, 11 variants distributed in\n                      <jats:italic>PKD1<\/jats:italic>\n                      (c.7866C\u2009&gt;\u2009A, c.7960A\u2009&gt;\u2009G, c.7979A\u2009&gt;\u2009T, c.7987C\u2009&gt;\u2009T, c.11248C\u2009&gt;\u2009G, c.11251C\u2009&gt;\u2009T, c.11257C\u2009&gt;\u2009G, c.11257C\u2009&gt;\u2009T, c.11346C\u2009&gt;\u2009T, and c.11393C\u2009&gt;\u2009G) and\n                      <jats:italic>PKD2<\/jats:italic>\n                      (c.1480G\u2009&gt;\u2009T) were identified to result in exon skipping.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We confirmed that 11 variants in the gene of\n                      <jats:italic>PKD1<\/jats:italic>\n                      and\n                      <jats:italic>PKD2<\/jats:italic>\n                      affect normal splicing by interfering the recognition of classical splicing sites or by disrupting exon splicing enhancers and generating exon splicing silencers. This is the most comprehensive study to date on pre-mRNA splicing of exonic variants in ADPKD-associated disease-causing genes in consideration of the increasing number of identified variants in\n                      <jats:italic>PKD1<\/jats:italic>\n                      and\n                      <jats:italic>PKD2<\/jats:italic>\n                      gene in recent years. These results emphasize the significance of assessing the effect of exon single nucleotide variants in ADPKD at the mRNA level.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12864-023-09444-9","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T05:03:27Z","timestamp":1689743007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identified eleven exon variants in PKD1 and PKD2 genes that altered RNA splicing by minigene assay"],"prefix":"10.1186","volume":"24","author":[{"given":"Xuyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leping","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"issue":"8","key":"9444_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","volume":"17","author":"SC Bonnal","year":"2020","unstructured":"Bonnal SC, L\u00f3pez-Oreja I, Valc\u00e1rcel J. Roles and mechanisms of alternative splicing in cancer - implications for care. Nat reviews Clin Oncol. 2020;17(8):457\u201374.","journal-title":"Nat reviews Clin Oncol"},{"issue":"6","key":"9444_CR2","doi-asserted-by":"publisher","first-page":"e0269159","DOI":"10.1371\/journal.pone.0269159","volume":"17","author":"Y Strauch","year":"2022","unstructured":"Strauch Y, Lord J, Niranjan M, Baralle D. CI-SpliceAI-Improving machine learning predictions of disease causing splicing variants using curated alternative splice sites. PLoS ONE. 2022;17(6):e0269159.","journal-title":"PLoS ONE"},{"issue":"9","key":"9444_CR3","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.febslet.2005.02.047","volume":"579","author":"N L\u00f3pez-Bigas","year":"2005","unstructured":"L\u00f3pez-Bigas N, Audit B, Ouzounis C, Parra G, Guig\u00f3 R. Are splicing mutations the most frequent cause of hereditary disease? FEBS Lett. 2005;579(9):1900\u20133.","journal-title":"FEBS Lett"},{"key":"9444_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/bs.adgen.2018.09.002","volume":"103","author":"LG Dufner-Almeida","year":"2019","unstructured":"Dufner-Almeida LG, do Carmo RT, Masotti C, Haddad LA. Understanding human DNA variants affecting pre-mRNA splicing in the NGS era. Adv Genet. 2019;103:39\u201390.","journal-title":"Adv Genet"},{"issue":"7","key":"9444_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00439-019-02036-2","volume":"138","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Deng H, Chen X, Li H, Yang C, Li S, et al. Skipping of an exon with a nonsense mutation in the DMD gene is induced by the conversion of a splicing enhancer to a splicing silencer. Hum Genet. 2019;138(7):771\u201385.","journal-title":"Hum Genet"},{"issue":"11\u201312","key":"9444_CR6","doi-asserted-by":"publisher","first-page":"194401","DOI":"10.1016\/j.bbagrm.2019.07.002","volume":"1862","author":"N Bartys","year":"2019","unstructured":"Bartys N, Kierzek R, Lisowiec-Wachnicka J. The regulation properties of RNA secondary structure in alternative splicing. Biochim et Biophys acta Gene Regul Mech. 2019;1862(11\u201312):194401.","journal-title":"Biochim et Biophys acta Gene Regul Mech"},{"issue":"10174","key":"9444_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet (London England). 2019;393(10174):919\u201335.","journal-title":"Lancet (London England)"},{"issue":"10","key":"9444_CR8","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1681\/ASN.2018050493","volume":"29","author":"MB Lanktree","year":"2018","unstructured":"Lanktree MB, Haghighi A, Guiard E, Iliuta IA, Song X, Harris PC, et al. Prevalence estimates of polycystic kidney and liver disease by Population sequencing. J Am Soc Nephrology: JASN. 2018;29(10):2593\u2013600.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"8","key":"9444_CR9","first-page":"1356","volume":"32","author":"CJ Willey","year":"2017","unstructured":"Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ, Czerwiec FS. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrology, dialysis, transplantation: official publication of the european Dialysis and Transplant Association -. Eur Ren Association. 2017;32(8):1356\u201363.","journal-title":"Eur Ren Association"},{"issue":"1","key":"9444_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2017050483","volume":"29","author":"E Cornec-Le Gall","year":"2018","unstructured":"Cornec-Le Gall E, Torres VE, Harris PC. Genetic complexity of autosomal Dominant Polycystic kidney and Liver Diseases. J Am Soc Nephrology: JASN. 2018;29(1):13\u201323.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"5","key":"9444_CR11","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1172\/JCI90129","volume":"127","author":"W Besse","year":"2017","unstructured":"Besse W, Dong K, Choi J, Punia S, Fedeles SV, Choi M, et al. Isolated polycystic liver disease genes define effectors of polycystin-1 function. J Clin Investig. 2017;127(5):1772\u201385.","journal-title":"J Clin Investig"},{"issue":"5","key":"9444_CR12","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","volume":"102","author":"E Cornec-Le Gall","year":"2018","unstructured":"Cornec-Le Gall E, Olson RJ, Besse W, Heyer CM, Gainullin VG, Smith JM, et al. Monoallelic mutations to DNAJB11 cause atypical Autosomal-Dominant polycystic kidney disease. Am J Hum Genet. 2018;102(5):832\u201344.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"9444_CR13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","volume":"98","author":"B Porath","year":"2016","unstructured":"Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, et al. Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause Autosomal-Dominant polycystic kidney and liver disease. Am J Hum Genet. 2016;98(6):1193\u2013207.","journal-title":"Am J Hum Genet"},{"issue":"9569","key":"9444_CR14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet (London England). 2007;369(9569):1287\u2013301.","journal-title":"Lancet (London England)"},{"issue":"10","key":"9444_CR15","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, et al. The human gene mutation database (HGMD(\u00ae)): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020;139(10):1197\u2013207.","journal-title":"Hum Genet"},{"issue":"4","key":"9444_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/15476286.2015.1014291","volume":"12","author":"F Claverie-Martin","year":"2015","unstructured":"Claverie-Martin F, Gonzalez-Paredes FJ, Ramos-Trujillo E. Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease. RNA Biol. 2015;12(4):369\u201374.","journal-title":"RNA Biol"},{"issue":"9","key":"9444_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/humu.24246","volume":"42","author":"R Zhang","year":"2021","unstructured":"Zhang R, Chen Z, Song Q, Wang S, Liu Z, Zhao X, et al. Identification of seven exonic variants in the SLC4A1, ATP6V1B1, and ATP6V0A4 genes that alter RNA splicing by minigene assay. Hum Mutat. 2021;42(9):1153\u201364.","journal-title":"Hum Mutat"},{"issue":"2","key":"9444_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.gene.2014.06.004","volume":"546","author":"FJ Gonzalez-Paredes","year":"2014","unstructured":"Gonzalez-Paredes FJ, Ramos-Trujillo E, Claverie-Martin F. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease. Gene. 2014;546(2):243\u20139.","journal-title":"Gene"},{"issue":"1","key":"9444_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.gene.2015.12.019","volume":"578","author":"FJ Gonzalez-Paredes","year":"2016","unstructured":"Gonzalez-Paredes FJ, Ramos-Trujillo E, Claverie-Martin F. Three exonic mutations in polycystic kidney disease-2 gene (PKD2) alter splicing of its pre-mRNA in a minigene system. Gene. 2016;578(1):117\u201323.","journal-title":"Gene"},{"issue":"3","key":"9444_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1399-0004.2010.01555.x","volume":"80","author":"YC Tan","year":"2011","unstructured":"Tan YC, Blumenfeld J, Michaeel A, Donahue S, Balina M, Parker T, et al. Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease. Clin Genet. 2011;80(3):287\u201392.","journal-title":"Clin Genet"},{"issue":"11","key":"9444_CR21","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1681\/ASN.V10112342","volume":"10","author":"DM Reynolds","year":"1999","unstructured":"Reynolds DM, Hayashi T, Cai Y, Veldhuisen B, Watnick TJ, Lens XM, et al. Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease. J Am Soc Nephrology: JASN. 1999;10(11):2342\u201351.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"3","key":"9444_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ygeno.2005.05.011","volume":"86","author":"Y Wu","year":"2005","unstructured":"Wu Y, Zhang Y, Zhang J. Distribution of exonic splicing enhancer elements in human genes. Genomics. 2005;86(3):329\u201336.","journal-title":"Genomics"},{"key":"9444_CR23","doi-asserted-by":"crossref","unstructured":"Rowlands CF, Baralle D, Ellingford JM. Machine learning approaches for the prioritization of genomic variants impacting Pre-mRNA splicing. Cells. 2019;8(12).","DOI":"10.3390\/cells8121513"},{"issue":"2\u20133","key":"9444_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/1066527041410418","volume":"11","author":"G Yeo","year":"2004","unstructured":"Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput biology: J Comput Mol cell biology. 2004;11(2\u20133):377\u201394.","journal-title":"J Comput biology: J Comput Mol cell biology"},{"issue":"1","key":"9444_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrg.2015.3","volume":"17","author":"MM Scotti","year":"2016","unstructured":"Scotti MM, Swanson MS. RNA mis-splicing in disease. Nat Rev Genet. 2016;17(1):19\u201332.","journal-title":"Nat Rev Genet"},{"key":"9444_CR26","doi-asserted-by":"crossref","unstructured":"Suarez-Artiles L, Perdomo-Ramirez A, Ramos-Trujillo E, Claverie-Martin F. Splicing analysis of exonic OCRL mutations causing Lowe Syndrome or Dent-2 Disease. Genes. 2018;9(1).","DOI":"10.3390\/genes9010015"},{"issue":"12","key":"9444_CR27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/ejhg.2014.40","volume":"22","author":"AY Steffensen","year":"2014","unstructured":"Steffensen AY, Dandanell M, J\u00f8nson L, Ejlertsen B, Gerdes AM, Nielsen FC, et al. Functional characterization of BRCA1 gene variants by mini-gene splicing assay. Eur J Hum genetics: EJHG. 2014;22(12):1362\u20138.","journal-title":"Eur J Hum genetics: EJHG"},{"key":"9444_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fgene.2018.00188","volume":"9","author":"E Fraile-Bethencourt","year":"2018","unstructured":"Fraile-Bethencourt E, Valenzuela-Palomo A, D\u00edez-G\u00f3mez B, Acedo A, Velasco EA. Identification of eight spliceogenic variants in BRCA2 exon 16 by Minigene assays. Front Genet. 2018;9:188.","journal-title":"Front Genet"},{"key":"9444_CR29","doi-asserted-by":"publisher","first-page":"585064","DOI":"10.3389\/fgene.2020.585064","volume":"11","author":"S Wang","year":"2020","unstructured":"Wang S, Wang Y, Wang J, Liu Z, Zhang R, Shi X, et al. Six Exonic Variants in the SLC5A2 gene cause exon skipping in a Minigene Assay. Front Genet. 2020;11:585064.","journal-title":"Front Genet"},{"issue":"2","key":"9444_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41581-018-0108-1","volume":"15","author":"VE Torres","year":"2019","unstructured":"Torres VE, Harris PC. Progress in the understanding of polycystic kidney disease. Nat Rev Nephrol. 2019;15(2):70\u20132.","journal-title":"Nat Rev Nephrol"},{"key":"9444_CR31","volume-title":"Structure of the human PKD1-PKD2 complex","author":"Q Su","year":"2018","unstructured":"Su Q, Hu F, Ge X, Lei J, Yu S, Wang T, et al. Structure of the human PKD1-PKD2 complex. Volume 361. New York, NY: Science; 2018. 6406."},{"issue":"5","key":"9444_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet medicine: official J Am Coll Med Genet. 2015;17(5):405\u201324.","journal-title":"Genet medicine: official J Am Coll Med Genet"},{"issue":"3","key":"9444_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ncb754","volume":"4","author":"P Koulen","year":"2002","unstructured":"Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, et al. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol. 2002;4(3):191\u20137.","journal-title":"Nat Cell Biol"},{"issue":"21","key":"9444_CR34","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1093\/hmg\/ddi356","volume":"14","author":"K Hackmann","year":"2005","unstructured":"Hackmann K, Markoff A, Qian F, Bogdanova N, Germino GG, Pennekamp P, et al. A splice form of polycystin-2, lacking exon 7, does not interact with polycystin-1. Hum Mol Genet. 2005;14(21):3249\u201362.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"9444_CR35","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1172\/JCI64313","volume":"122","author":"K Hopp","year":"2012","unstructured":"Hopp K, Ward CJ, Hommerding CJ, Nasr SH, Tuan HF, Gainullin VG, et al. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J Clin Investig. 2012;122(11):4257\u201373.","journal-title":"J Clin Investig"},{"issue":"24","key":"9444_CR36","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/hmg\/ddh336","volume":"13","author":"IS Lantinga-van Leeuwen","year":"2004","unstructured":"Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ, Leonhard WN, van de Wal A, Ward CJ, et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet. 2004;13(24):3069\u201377.","journal-title":"Hum Mol Genet"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-023-09444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-023-09444-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-023-09444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T06:02:37Z","timestamp":1700632957000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-023-09444-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["9444"],"URL":"https:\/\/doi.org\/10.1186\/s12864-023-09444-9","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"8 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}